BELLEVUE, Wash., May 9, 2011 /PRNewswire/ -- drugstore.com, inc.
(NASDAQ: DSCM), a leading online retailer of health, beauty,
clinical skincare, and vision products, today announced the
expiration of the waiting period under the U.S. Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (HSR Act), with
respect to the proposed merger previously announced on March 24, 2011 pursuant to which drugstore.com
would be acquired by Walgreen Co. in a cash transaction.
Accordingly, the merger closing condition with respect to the
expiration or termination of the waiting period under the HSR Act
has been satisfied. Completion of the merger remains subject to
satisfaction or waiver of certain other conditions, including
approval by the stockholders of drugstore.com. The parties
continue to expect the transaction to close in June 2011.
(Logo:
http://photos.prnewswire.com/prnh/20070813/AQM043LOGO)
About drugstore.com, inc.
drugstore.com, inc. (Nasdaq:DSCM) is a leading online retailer
of health, beauty, clinical skincare, and vision products. Our
portfolio of brands includes: drugstore.com™, Beauty.com™,
SkinStore.com™, and VisionDirect.com™. All provide a convenient,
private, and informative shopping experience, while offering a wide
assortment of more than 55,000 non-prescription products at
competitive prices.
The drugstore.com pharmacy service, in association with BioScrip
Pharmacy Services, Inc., is certified by the National Association
of Boards of Pharmacy (NABP) as a Verified Internet Pharmacy
Practice Site (VIPPS) and complies with federal and state laws and
regulations in the United
States.
The drugstore.com, inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6419
This press release contains forward-looking statements regarding
future events leading up to and including the potential
consummation of a merger of drugstore.com with a subsidiary of
Walgreens. Forward-looking statements are based on current
expectations, are not guarantees of future performance and involve
assumptions, risks, and uncertainties. Actual performance may
differ materially from those contained or implied in such
forward-looking statements. Risks and uncertainties that could lead
to such differences could include, among other things: the ability
of the parties to consummate the proposed merger on the terms
described in this release, or at all; the satisfaction of the
various closing conditions to the proposed merger; the ability to
realize anticipated benefits of the proposed merger; and other
factors affecting ecommerce and other retail markets generally.
Additional information regarding factors that potentially could
affect the business, financial condition, and operating results of
drugstore.com, inc. is included in the Company's periodic filings
with the SEC on Forms 10-K, 10-Q, and 8-K. drugstore.com, inc.
expressly disclaims any intent or obligation to update any
forward-looking statement, except as otherwise specifically stated
by it.
Investor Relations:
Brinlea Johnson
212-551-1453
brinlea@blueshirtgroup.com
SOURCE drugstore.com, inc.